Nguyen TH, Thrift AP, Rugge M, El-Serag HB. Prevalence of Barrett’s esophagus and performance of societal screening guidelines in an unreferred primary care population of U.S. veterans. Gastrointest Endosc 2021; 93: 409-419.e401.

Article  PubMed  Google Scholar 

Qumseya B, Sultan S, Bain P et al. ASGE guideline on screening and surveillance of Barrett’s esophagus. Gastrointest Endosc 2019; 90: 335-359.e332.

Article  PubMed  Google Scholar 

Crowe B, Krigel A, Li T et al. Veterans with multiple risk factors for Barrett’s esophagus are infrequently evaluated with upper endoscopy. Dis Esophagus 2023; 36: 1-8.

Article  Google Scholar 

Cook MB, Thrift AP. Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance. Gastrointest Endosc Clin N Am 2021; 31: 1-26.

Article  PubMed  Google Scholar 

Wenker TN, Thrift AP, El-Serag HB. Limits of the AGA Practice Update for Barrett’s Esophagus Screening: A Proposal for Electronic Health Record-Adaptable Risk Models. Clin Gastroenterol Hepatol 2022.

Levy BH, 3rd, Thelin C, Da Silva J. 45 Is the new 50: improving colon cancer screening rates. Curr Opin Gastroenterol 2023; 39: 31-35.

Article  PubMed  Google Scholar 

Rubenstein JH, Evans RR, Burns JA et al. Patients With Adenocarcinoma of the Esophagus or Esophagogastric Junction Frequently Have Potential Screening Opportunities. Gastroenterology 2022; 162: 1349-1351.e1345.

Article  PubMed  Google Scholar 

Baldwin-Hunter BL, Knotts RM, Leeds SD et al. Use of the Electronic Health Record to Target Patients for Non-endoscopic Barrett’s Esophagus Screening. Dig Dis Sci 2019; 64: 3463-3470.

Article  PubMed  PubMed Central  Google Scholar 

Kamboj AK, Katzka DA, Iyer PG. Endoscopic Screening for Barrett’s Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges. Gastrointest Endosc Clin N Am 2021; 31: 27-41.

Article  Google Scholar 

Planade O, Dessomme B, Chapelle N et al. Systematic upper endoscopy concomitant with colonoscopy performed within the colorectal cancer screening program: Impact on the patients’ management. Clin Res Hepatol Gastroenterol 2021; 45: 101501.

Article  Google Scholar 

Rubenstein JH, Omidvari AH, Lauren BN et al. Endoscopic Screening Program for Control of Esophageal Adenocarcinoma in Varied Populations: A Comparative Cost-Effectiveness Analysis. Gastroenterology 2022; 163: 163-173.

Article  PubMed  Google Scholar 

Gupta N, Bansal A, Wani SB et al. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis. Gastrointest Endosc 2011; 74: 610-624.e612.

Article  PubMed  Google Scholar 

Otaki F, Iyer PG. Point-Counterpoint: Screening and Surveillance for Barrett’s Esophagus, Is It Worthwhile? Dig Dis Sci 2018; 63: 2081-2093.

Article  PubMed  Google Scholar 

Abrams JA, Kapel RC, Lindberg GM et al. Adherence to biopsy guidelines for Barrett’s esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol 2009; 7: 736–742; quiz 710.

Roumans CAM, van der Bogt RD, Steyerberg EW et al. Adherence to recommendations of Barrett’s esophagus surveillance guidelines: a systematic review and meta-analysis. Endoscopy 2020; 52: 17-28.

Article  PubMed  Google Scholar 

Roumans CAM, van der Bogt RD, Nieboer D et al. Clinical consequences of nonadherence to Barrett’s esophagus surveillance recommendations: a Multicenter prospective cohort study. Dis Esophagus 2022.

Saxena N, Inadomi JM. Effectiveness and Cost-Effectiveness of Endoscopic Screening and Surveillance. Gastrointest Endosc Clin N Am 2017; 27: 397-421.

Article  PubMed  Google Scholar 

Klair JS, Zafar Y, Nagra N et al. Outcomes of Radiofrequency Ablation versus Endoscopic Surveillance for Barrett’s Esophagus with Low-Grade Dysplasia: A Systematic Review and Meta-Analysis. Dig Dis 2021; 39: 561-568.

Article  PubMed  Google Scholar 

de Matos MV, da Ponte-Neto AM, de Moura DTH et al. Treatment of high-grade dysplasia and intramucosal carcinoma using radiofrequency ablation or endoscopic mucosal resection + radiofrequency ablation: Meta-analysis and systematic review. World J Gastrointest Endosc 2019; 11: 239-248.

Article  PubMed  PubMed Central  Google Scholar 

Grant KS, DeMeester SR, Kreger V et al. Effect of Barrett’s esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2013; 146: 31-37.

Article  PubMed  Google Scholar 

Holmberg D, Ness-Jensen E, Mattsson F, Lagergren J. Endoscopy for gastroesophageal reflux disease and survival in esophageal adenocarcinoma. Int J Cancer 2020; 147: 93-99.

Article  CAS  PubMed  Google Scholar 

Kastelein F, van Olphen SH, Steyerberg EW et al. Impact of surveillance for Barrett’s oesophagus on tumour stage and survival of patients with neoplastic progression. Gut 2016; 65: 548-554.

Article  CAS  PubMed  Google Scholar 

Stukalin I, Ahmed NS, Fundytus AM et al. Trends and Projections in National United States Health Care Spending for Gastrointestinal Malignancies (1996–2030). Gastroenterology 2022; 162: 1098–1110.e1092.

Inadomi JM, Saxena N. Screening and Surveillance for Barrett’s Esophagus: Is It Cost-Effective? Dig Dis Sci 2018; 63: 2094-2104.

Article  PubMed  Google Scholar 

Tramontano AC, Chen Y, Watson TR et al. Esophageal cancer treatment costs by phase of care and treatment modality, 2000-2013. Cancer Med 2019; 8: 5158-5172.

Article  PubMed  PubMed Central  Google Scholar 

Abraham P, Wang L, Jiang Z et al. Healthcare utilization and total costs of care among patients with advanced metastatic gastric and esophageal cancer. Future Oncol 2021; 17: 291-299.

Article  CAS  PubMed  Google Scholar 

Pech O, Behrens A, May A et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 2008; 57: 1200-1206.

Article  CAS  PubMed  Google Scholar